Opgen Inc financial data

Symbol
OPGN on Nasdaq
Industry
Services-Medical Laboratories
Location
9717 Key West Avenue, Suite 100, Rockville, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q3 2023 - Nov 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 72.7 % -55.5%
Quick Ratio 30.5 % +13.1%
Debt-to-equity 253 % +193%
Return On Equity -398 % -246%
Return On Assets -113 % -82.7%
Operating Margin -773 % +15.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10M shares -81.4%
Common Stock, Shares, Outstanding 10M shares -79.3%
Entity Public Float 25.3M USD -70.8%
Common Stock, Value, Issued 100K USD -79.3%
Weighted Average Number of Shares Outstanding, Basic 8.78M shares +268%
Weighted Average Number of Shares Outstanding, Diluted 8.78M shares +268%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.07M USD -7.28%
Revenue from Contract with Customer, Excluding Assessed Tax 699K USD +55.8%
Research and Development Expense 5.96M USD -37.2%
Selling and Marketing Expense 3.61M USD -15.1%
General and Administrative Expense 8.99M USD -3.06%
Costs and Expenses 26.8M USD -20.5%
Operating Income (Loss) -23.7M USD +22%
Nonoperating Income (Expense) -2.43M USD +21.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.2M USD +21.9%
Net Income (Loss) Attributable to Parent -26.2M USD +22%
Earnings Per Share, Basic -6.55 USD/shares +80.4%
Earnings Per Share, Diluted -6.55 USD/shares +92.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 293K USD -97.2%
Accounts Receivable, after Allowance for Credit Loss, Current 423K USD -36.5%
Inventory, Net 2.81M USD -17.1%
Assets, Current 3.45M USD -74.2%
Property, Plant and Equipment, Net 3.82M USD +25.1%
Operating Lease, Right-of-Use Asset 1.92M USD +30%
Goodwill 6.88M USD -11.6%
Other Assets, Noncurrent 492K USD +17.3%
Assets 18.1M USD -45%
Accounts Payable, Current 905K USD +32.5%
Employee-related Liabilities, Current 382K USD -72.6%
Accrued Liabilities, Current 1.27M USD +21.2%
Contract with Customer, Liability, Current 195K USD
Liabilities, Current 12.5M USD +3.83%
Operating Lease, Liability, Noncurrent 2.83M USD +7.54%
Other Liabilities, Noncurrent 121K USD -0.06%
Liabilities 15.5M USD -18.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -678K USD +59.2%
Retained Earnings (Accumulated Deficit) -288M USD -9.97%
Stockholders' Equity Attributable to Parent 2.68M USD -80.8%
Liabilities and Equity 18.1M USD -45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.96M USD +1.56%
Net Cash Provided by (Used in) Financing Activities 4.74M USD
Net Cash Provided by (Used in) Investing Activities -330K USD -754%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 10M shares -79.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -399K USD +92.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 785K USD -92.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 56.3K USD +4929%
Deferred Tax Assets, Valuation Allowance 106M USD -0.03%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 107M USD -0.2%
Depreciation 831K USD -46.1%
Payments to Acquire Property, Plant, and Equipment 330K USD +754%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -25.2M USD +31.3%
Property, Plant and Equipment, Gross 7.52M USD -0.41%
Operating Lease, Liability, Current 521K USD +50.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 102M USD -0.29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 138K USD -21.2%
Additional Paid in Capital 292M USD +5.16%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 729K USD +2.74%
Depreciation, Depletion and Amortization 350K USD -31.9%
Deferred Tax Assets, Net of Valuation Allowance 106M USD 0%
Interest Expense 2.34M USD -39%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%